Discontinued — last reported Q3 '24
Non-Current Liabilities
Operating Lease Liability Payments - 2028 (Lessee)
West Pharmaceutical Services Operating Lease Liability Payments - 2028 (Lessee) decreased by 18.1% to $10.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $12.30M to $10.40M. Over 3 years (FY 2020 to FY 2023), Operating Lease Liability Payments - 2028 (Lessee) shows relatively stable performance with a 3.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
First reportedQ1 2020
Last reportedQ3 2024
Metric ID:
lease_liability_payments_2028_lesseeHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.90M | $6.80M | $8.20M | $8.40M | $8.70M | $11.60M | $13.40M | $9.30M | $9.40M | $9.80M | $9.50M | $10.10M | $13.80M | $14.10M | $12.30M | $12.80M | $12.70M | $10.40M |
| QoQ Change | — | -1.4% | +20.6% | +2.4% | +3.6% | +33.3% | +15.5% | -30.6% | +1.1% | +4.3% | -3.1% | +6.3% | +36.6% | +2.2% | -12.8% | +4.1% | -0.8% | -18.1% |
| YoY Change | — | — | — | — | +26.1% | +70.6% | +63.4% | +10.7% | +8.0% | -15.5% | -29.1% | +8.6% | +46.8% | +43.9% | +21.8% | -7.2% | -9.9% | -15.4% |
Range$6.80M – $14.10M
CAGR+10.1%
Avg YoY Growth+15.9%
Median YoY Growth+9.7%
Current Streak2 quarters decline
Operating Lease Liability Payments - 2028 (Lessee) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's operating lease liability payments - 2028 (lessee)?
- West Pharmaceutical Services (WST) reported operating lease liability payments - 2028 (lessee) of $10.40M in Q1 2026.
- How has West Pharmaceutical Services's operating lease liability payments - 2028 (lessee) changed year-over-year?
- West Pharmaceutical Services's operating lease liability payments - 2028 (lessee) decreased by 15.4% year-over-year, from $12.30M to $10.40M.
- What is the long-term trend for West Pharmaceutical Services's operating lease liability payments - 2028 (lessee)?
- Over 3 years (2020 to 2023), West Pharmaceutical Services's operating lease liability payments - 2028 (lessee) has grown at a 3.0% compound annual growth rate (CAGR), from $8.70M to $9.50M.